BASEL, Switzerland, May 1 (TNSrep) -- Roche, a biotech company, issued the following news release on April 30, 2026:

* * *

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

* New real-world data confirm Vabysmo's potent retinal drying in nAMD and DME

* Key data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing treatment bur . . .

Click here for more information about our products